Clinical Trial Update: SI-B001 as a Single Agent or in Combination With Chemotherapy in the Treatment of Digestive System Malignancies [Phase 2]

View source ↗

Summary

Phase 2 trial of SI-B001 for digestive system malignancies, including colorectal cancer, as a single agent or with chemotherapy, has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• SI-B001

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Colorectal Cancer | Phase 2 | Status: TERMINATED